Table 1.
Characteristics of participants allocated to TAU, PMIT and CCT
TAU (n = 20) | PMIT (n = 18) | CCT (n = 19) | |
---|---|---|---|
Age, years, mean (s.d.) | 46.55 (13.32) | 43.11 (14.93) | 45.53 (11.98) |
Gender, female, n (%) | 9 (45.00%) | 9 (50.00%) | 10 (52.63%) |
Marital status, n (%) | |||
Single | 6 (30.00%) | 5 (27.78%) | 8 (42.11%) |
Partnership/married | 11 (55.00%) | 10 (55.56%) | 9 (47.37%) |
Divorced | 3 (15.00%) | 2 (11.11%) | 1 (5.26%) |
Widowed | 0 (0.00%) | 1 (5.56%) | 1 (5.26%) |
Education, n (%) | |||
Doctorate | 1 (5.00%) | 1 (5.56%) | 0 (0.00%) |
University degree | 9 (45.00%) | 7 (38.89%) | 8 (42.11%) |
Final secondary school examination | 5 (25.00%) | 2 (11.11%) | 3 (15.79%) |
Other school level qualification | 5 (25.00%) | 7 (38.89%) | 7 (36.84%) |
No educational qualification | 0 (0.00%) | 1 (5.56%) | 1 (5.26%) |
Employment status, n (%) | |||
In paid employment | 16 (80.00%) | 12 (66.67%) | 12 (63.16%) |
Student/trainee | 0 (0.00%) | 1 (5.56%) | 0 (0.00%) |
Self-employed | 0 (0.00%) | 1 (5.56%) | 2 (10.53%) |
Not in employment | 4 (20.00%) | 3 (16.67%) | 4 (21.05%) |
Pensioner | 0 (0.00%) | 1 (5.56%) | 1 (5.26%) |
Household income, n (%)a | |||
≥€5100 | 6 (30.00%) | 4 (23.53%) | 5 (27.78%) |
€3100–€5099 | 6 (30.00%) | 3 (17.65%) | 2 (11.11%) |
€900–€3099 | 5 (25.00%) | 8 (47.06%) | 9 (50.00%) |
<€899 | 3 (15.00%) | 2 (11.76%) | 2 (11.11%) |
Medication, n (%) | |||
Any psychiatric medication | 14 (70.00%) | 14 (77.78%) | 13 (68.42%) |
Antidepressant | 12 (60.00%) | 14 (77.78%) | 12 (63.16%) |
Anxiolytic | 2 (10.00%) | 1 (5.56%) | 2 (10.53%) |
Antipsychotic | 4 (20.00%) | 5 (27.78%) | 5 (26.32%) |
Mood stabiliser/anticonvulsant | 3 (15.00%) | 4 (22.22%) | 1 (5.26%) |
Other psychoactive (e.g. stimulant) | 0 (0.00%) | 2 (11.11%) | 3 (15.79%) |
Psychological diagnoses, n (%) | |||
Depression | 15 (75.00%) | 10 (55.56%) | 10 (52.63%) |
Anxiety | 4 (20.00%) | 9 (50.00%) | 4 (21.05%) |
Substance misuse/dependence disorder | 1 (5.00%) | 2 (11.11%) | 5 (26.32%) |
Others | 7 (35.00%) | 8 (44.44%) | 9 (47.37%) |
Duration of clinic stay beforehand, days, mean (s.d.) | 17.05 (18.01) | 11.50 (11.36) | 16.79 (18.87) |
Baseline measures, mean (s.d.) | |||
PANAS-P | 45.45 (13.59) | 46.94 (13.50) | 44.89 (14.93) |
DARS | 70.06 (20.49) | 67.76 (19.62) | 75.76 (15.40) |
QIDS-SR | 12.90 (4.73) | 12.44 (5.62) | 12.37 (5.75) |
GAD-7 | 10.60 (4.41) | 10.22 (5.86) | 11.05 (5.54) |
PMH | 10.40 (5.50) | 9.50 (6.62) | 9.68 (6.86) |
PIT positive | 13.00 (4.81) | 12.11 (5.43) | 13.11 (4.83) |
PIT negative | 14.60 (5.17) | 15.28 (4.71) | 15.74 (4.00) |
SST | 0.31 (0.23) | 0.42 (0.35) | 0.35 (0.30) |
TAU, treatment as usual; PMIT, positive mental imagery training; CCT, cognitive control training; PANAS-P, Positive and Negative Affect Schedule; DARS, Dimensional Anhedonia Rating Scale; QIDS-SR, Quick Inventory of Depressive Symptomatology – Self Report; GAD-7, Generalized Anxiety Disorder-7; PMH, Positive Mental Health scale; PIT, Prospective Imagery Test; SST, Scrambled Sentences Test.
PMIT: n = 17; CCT: n = 18.